Overview
As a core branch of proteomics, modification proteomics enables systematic identification and quantification of protein post-translational modifications (PTMs). It analyzes dynamic variations in modification sites and modification abundance, and elucidates the regulatory mechanisms by which PTMs govern protein functions as well as cellular physiological and pathological processes. After proteins are translated by ribosomes, covalent chemical modifications can occur on their amino acid residues. Such modifications do not alter gene sequences yet greatly expand the functional diversity of proteins. Unlike conventional global proteomics, which only detects total protein expression levels, modification proteomics centers its research on diverse modification events.
Product Topics
Subcategories
EpigenomicEpigenomicEpigenomics refers to the systematic study of epigenetic modifications across the entire genome. Epigenetic modifications do not alter the primary DNA sequence, yet they regulate gene activities through chemical modifications, including DNA methylation, histone modifications and non-covalent RNA regulation. Based on high-throughput sequencing technologies, epigenomics characterizes epigenetic profiles of cells and tissues, and explores the epigenetic mechanisms underlying cell development and pathogenesis. Unlike genomics focusing on genomic DNA sequences, epigenomics centers on the regulatory effects of epigenetic modifications on gene expression.
>> View productsPTMPTMProtein post-translational modifications (PTMs) are covalent chemical modifications occurring after protein synthesis that expand proteomic diversity and regulate protein properties and functions. More than 650 types of PTMs have been identified, including phosphorylation, acylation, ubiquitination, methylation, and glycosylation. PTMs dynamically modulate protein function by influencing molecular properties such as enzymatic activity, stability, localization, conformation, and molecular interactions. These regulatory events are essential for diverse cellular processes, including signal transduction, gene regulation, metabolism, and immune responses. Aberrant PTMs regulation can perturb cellular signaling networks and contribute to disease initiation and progression. Dysregulated PTMs are increasingly recognized as important molecular drivers and biomarkers in various diseases, providing valuable opportunities for disease mechanism studies and therapeutic development.
>> View productsTry another keyword, SKU, CAS number, or product category.
